Showing results (181-190 of 237) with videos related to

Sort By:
Pageof 24
Lung Cancer (Amsterdam, Netherlands)|May 11, 2020
Addition of ramucirumab enhances docetaxel efficacy in patients who had received anti-PD-1/PD-L1 treatmentTakehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto, et al.
Thoracic Cancer|February 26, 2020
Immune checkpoint inhibitor-associated interstitial lung diseases correlate with better prognosis in patients with advanced non-small-cell lung cancerTeppei Sugano, Masahiro Seike, Yoshinobu Saito, et al.
BMC Cancer|March 14, 2020
Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitorsTakehiro Tozuka, Satoru Kitazono, Hiroaki Sakamoto, et al.
Respiratory Medicine Case Reports|February 7, 2019
Anti-MDA5 antibody-positive rapidly progressive interstitial pneumonia without cutaneous manifestationsJunichi Aoyama, Hiroki Hayashi, Chika Yajima, et al.
International Journal of Clinical Oncology|July 29, 2019
Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II studyAya Fukuizumi, Yuji Minegishi, Miwako Omori, et al.
Experimental Cell Research|December 11, 2020
Rictor-targeting exosomal microRNA-16 ameliorates lung fibrosis by inhibiting the mTORC2-SPARC axisMinoru Inomata, Koichiro Kamio, Arata Azuma, et al.
British Journal of Cancer|November 27, 2020
Pharmacological blockage of transforming growth factor-β signalling by a Traf2- and Nck-interacting kinase inhibitor, NCB-0846Teppei Sugano, Mari Masuda, Fumitaka Takeshita, et al.
ESMO Open|March 6, 2018
Oral rehydration solution (OS-1) as a substitute of intravenous hydration after cisplatin administration in patients with lung cancer: a prospective multicenter trialHidehito Horinouchi, Kaoru Kubota, Akihiko Miyanaga, et al.
Genes, Chromosomes & Cancer|April 16, 2003
Increased expression of the LGALS3 (galectin 3) gene in human non-small-cell lung cancerAkinobu Yoshimura, Akihiko Gemma, Yoko Hosoya, et al.
Lung Cancer (Amsterdam, Netherlands)|February 10, 2022
Deciphering the clinical features of heterogeneous stage III non-small cell lung cancer in Japanese real-world clinical practice: Expanded cohort of the SOLUTION studyHaruyasu Murakami, Hidehito Horinouchi, Hideyuki Harada, et al.
Pageof 24